Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Pacing Clin Electrophysiol. 2021 Jul;44(7):1193-1199. doi: 10.1111/pace.14289. Epub 2021 Jun 16.
To investigate the efficacy and safety of His-bundle pacing (HBP) compared with the traditional biventricular pacing (BVP) on patients with brady-arrhythmias, who suffer from permanent atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF).
All patients with brady-arrhythmias, permanent AF and HFrEF were continuously enrolled from January 2017 to July 2019 and followed up for at least 12 months. The differences in QRS duration (QRSd), New York Heart Association (NYHA) classification, left ventricular ejection fraction (LVEF), tricuspid regurgitation grade, mitral regurgitation grade, left ventricular end-diastolic diameter (LVEDD), and left atrial size were compared.
A total of 52 patients were enrolled: 37 patients were with HBP and 15 patients with BVP. There was no electrode dislodged, perforation, infection or thrombosis during the follow-up of 18.12 ± 4.45 months. The success rate for HBP implantation was 88.10%. The capture threshold of his-bundle and the threshold of the left ventricular lead remained stable during follow-up. LVEF increased to higher than 50% in 11 patients with HBP (29.73%). The NYHA classification (both p < .001), LVEF (both p < .001) and LVEDD improved significantly during the follow-up in both groups. NYHA (p = .030), LVEF (p = .013), and LVEDD (p = .003) improved in patients with HBP compared with BVP.
HBP was safe and more effective in improving the cardiac function and remodeling in patients with brady-arrhythmias, permanent AF and HFrEF compared with BVP.
研究希氏束起搏(HBP)与传统双心室起搏(BVP)治疗永久性心房颤动(AF)合并射血分数降低的心力衰竭(HFrEF)伴缓慢性心律失常患者的疗效和安全性。
连续纳入 2017 年 1 月至 2019 年 7 月期间因缓慢性心律失常、永久性 AF 和 HFrEF 就诊的患者,并进行至少 12 个月的随访。比较 QRS 时限(QRSd)、纽约心脏协会(NYHA)心功能分级、左心室射血分数(LVEF)、三尖瓣反流程度、二尖瓣反流程度、左心室舒张末期内径(LVEDD)和左心房内径的差异。
共纳入 52 例患者:HBP 组 37 例,BVP 组 15 例。随访 18.12±4.45 个月期间,无电极脱位、穿孔、感染或血栓形成。HBP 植入成功率为 88.10%。随访期间,希氏束夺获阈值和左心室导线阈值保持稳定。HBP 组 11 例(29.73%)LVEF 增加至 50%以上。两组随访期间 NYHA 心功能分级(均 P<0.001)、LVEF(均 P<0.001)和 LVEDD 均显著改善。与 BVP 组相比,HBP 组 NYHA(P=0.030)、LVEF(P=0.013)和 LVEDD(P=0.003)改善更明显。
与 BVP 相比,HBP 治疗永久性 AF 合并 HFrEF 伴缓慢性心律失常患者安全有效,可改善心功能和心室重构。